新脓毒症定义(Sepsis-3)与社区获得性肺炎死亡率:一项验证与临床决策研究
本研究为西班牙两所大学医院的队列研究,纳入6874例急诊成人社区获得性肺炎患者,比较SIRS、qSOFA、CRB、mSOFA、CURB-65和PSI对院内死亡的预测与临床决策价值。442例(6.4%)发生院内死亡。SIRS判别能力最差,qSOFA和mSOFA对死亡率高估和校准不良更明显;SIRS净获益低于qSOFA和CRB,显著增加过度治疗风险,与「全部治疗」策略相当。PSI对死亡的净获益高于mSOFA和CURB-65,而mSOFA在考虑死亡/ICU入住时似乎更适用。Sepsis-3流程图能更好识别高死亡风险患者。
要点
- 在急诊社区获得性肺炎患者中,qSOFA和CRB作为快速筛查工具的临床实用性优于SIRS,SIRS净获益低且过度治疗风险显著增加。
- 综合评估工具中,PSI对院内死亡的净获益高于mSOFA和CURB-65,决策辅助表现最佳。
- qSOFA和mSOFA对院内死亡率存在过度估计和校准不良,使用时需注意。
- Sepsis-3流程图较原有标准能更好识别高死亡风险的社区获得性肺炎患者。
- mSOFA在同时考虑死亡和ICU入住时似乎比PSI更适用。
适用人群与场景
- 西班牙两所大学医院急诊科就诊的成人社区获得性肺炎患者。
研究设计与关键结果
- 研究类型为队列研究,纳入6874例急诊成人社区获得性肺炎患者,来自两所西班牙大学医院。
- 主要终点为院内死亡,442例(6.4%)发生院内死亡。
- 判别能力由差到好依次为:SIRS、qSOFA、CRB、mSOFA、CURB-65、PSI。
- qSOFA和mSOFA对院内死亡率的高估和校准不良更明显。
- SIRS净获益低于qSOFA和CRB,显著增加过度治疗风险,与「全部治疗」策略相当。
- PSI对死亡的净获益高于mSOFA和CURB-65;mSOFA在考虑死亡/ICU入住时似乎更适用。
- Sepsis-3流程图能更好识别高死亡风险患者。
证据类型、等级与局限
- 证据类型:队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在急诊社区获得性肺炎患者中,qSOFA和CRB可作为快速筛查工具,其临床实用性优于SIRS。
- SIRS净获益低且显著增加过度治疗风险,与「全部治疗」策略相当,不宜单独用于筛查。
- 综合评估时,PSI对院内死亡的决策辅助表现最佳,净获益高于mSOFA和CURB-65。
- qSOFA和mSOFA可能高估死亡率且校准不良,解读评分时需谨慎。
- 当同时考虑死亡和ICU入住时,mSOFA似乎比PSI更适用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: The Sepsis-3 Task Force updated the clinical criteria for sepsis, excluding the need for systemic inflammatory response syndrome (SIRS) criteria. The clinical implications of the proposed flowchart including the quick Sequential (Sepsis-related) Organ Failure Assessment (qSOFA) and SOFA scores are unknown.
OBJECTIVES: To perform a clinical decision-making analysis of Sepsis-3 in patients with community-acquired pneumonia.
METHODS: This was a cohort study including adult patients with community-acquired pneumonia from two Spanish university hospitals. SIRS, qSOFA, the Confusion, Respiratory Rate and Blood Pressure (CRB) score, modified SOFA (mSOFA), the Confusion, Urea, Respiratory Rate, Blood Pressure and Age (CURB-65) score, and Pneumonia Severity Index (PSI) were calculated with data from the emergency department. We used decision-curve analysis to evaluate the clinical usefulness of each score and the primary outcome was in-hospital mortality.
MEASUREMENTS AND MAIN RESULTS: Of 6,874 patients, 442 (6.4%) died in-hospital. SIRS presented the worst discrimination, followed by qSOFA, CRB, mSOFA, CURB-65, and PSI. Overall, overestimation of in-hospital mortality and miscalibration was more evident for qSOFA and mSOFA. SIRS had lower net benefit than qSOFA and CRB, significantly increasing the risk of over-treatment and being comparable with the "treat-all" strategy. PSI had higher net benefit than mSOFA and CURB-65 for mortality, whereas mSOFA seemed more applicable when considering mortality/intensive care unit admission. Sepsis-3 flowchart resulted in better identification of patients at high risk of mortality.
CONCLUSIONS: qSOFA and CRB outperformed SIRS and presented better clinical usefulness as prompt tools for patients with community-acquired pneumonia in the emergency department. Among the tools for a comprehensive patient assessment, PSI had the best decision-aid tool profile.
参考来源
- Ranzani OT, Prina E, Menéndez R, et al. New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality. A Validation and Clinical Decision-Making Study. Am J Respir Crit Care Med. 2017. PMID: 28613918. doi:10.1164/rccm.201611-2262OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。